Larvol Delta - Eisai-Co-Ltd-and-Biogenannounced-today-that-39LEQEMBI-Pen39-the-subcutaneous-SC-formulation-of-the-antiamyloid-beta-A-protobril-antibody-39LEQEMBI39-brand-name-generic-name-lecanemab-has-been-approved-in-Japan-as-a-new-route-of-administration

Rituxan (rituximab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42746215

Anne-Marie Lavigne; Valérie Gagnon Bruneau

Sep 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next